Orchid Chemicals Soars 16% on FDA Nod for Anti-Bacterial Drug

Mumbai: Shares of Orchid Chemicals & Pharmaceuticals surged over 16 per cent on Thursday after the drug firm received nod from the US health regulator for generic anti-bacterial Gemifloxacin Mesylate tablets. The stock soared 16.31 per cent to Rs 57.40 at the BSE at its day's high. Orchid Chemicals in a statement to the BSE said that it has received approval from the US FDA for the abbreviated new drug application (ANDA) for Gemifl...